Headlines
Netherlands pushes for more generic drug imports from India
Published by Global Banking & Finance Review®
Posted on September 5, 2025
2 min readLast updated: January 22, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on September 5, 2025
2 min readLast updated: January 22, 2026
The Netherlands seeks to increase Indian generic drug imports to diversify its pharmaceutical market and reduce supply constraints.
By Rishika Sadam and Sriparna Roy
NEW DELHI (Reuters) -The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply constraints, Dutch government officials and industry experts said at an event on Friday.
India, popularly referred to as the 'pharmacy of the world, exported $616 million worth of drugs in fiscal year 2025 to the Netherlands, making it India's seventh largest export market.
The biggest market for India is the U.S., where tariff concerns linger. India mostly exports generic drugs that are cheaper versions of popular innovative drugs.
"The Netherlands has a generic uptake of 80% for annual prescriptions... Four out of 5 medicines going to patients are generic drugs," Kayleigh van Winssen, deputy director of pharmaceutical affairs at the Netherlands ministry of health, said at the International Pharmaceutical Exhibition in New Delhi.
There are over 22,000 medicines authorized for use in the Netherlands, she noted.
The European nation encouraged Indian drug manufacturers to increase exports to the Netherlands and across therapy areas.
The Netherlands delegation said at the event that the country is looking to diversify its portfolio and reduce dependence on single drug suppliers or those with extremely high market share.
There has been a 50% drop in generic medicine registrations in the last five years, with fewer generic products in the market, according to Leon Tinke, managing director of BENU, one of the largest pharmacy chains in the Netherlands.
Under an existing agreement between India and the Netherlands, the countries have been collaborating to train inspectors to learn about the regulatory process.
"Indian inspectors (are) being trained in the Netherlands from both the national and state level...We already had a training in January and other trainings are being lined up," said Winssen.
"We are also thinking about how we can provide companies with better information," she said.
(Reporting by Rishika Sadam and Sriparna Roy in New Delhi; Editing by Shinjini Ganguli)
The Netherlands aims to increase imports of Indian generic drugs to diversify its portfolio and avoid supply constraints.
India exported $616 million worth of drugs to the Netherlands in fiscal year 2025, making it India's seventh largest export market.
The Netherlands has a generic uptake of 80% for annual prescriptions, meaning four out of five medicines going to patients are generic.
There has been a 50% drop in generic medicine registrations in the last five years, leading to fewer generic products in the market.
Under an existing agreement, India and the Netherlands are collaborating to train inspectors about the regulatory process.
Explore more articles in the Headlines category
